Johnson & Johnson researches, develops, manufactures, and sells healthcare products worldwide. Its Innovative Medicine segment offers products for various therapeutic areas, including immunology, infectious diseases, oncology, cardiovascular, and more. The MedTech segment provides Interventional Solutions, including electrophysiology products and neurovascular care. It also offers orthopaedics, surgery portfolios, contact lenses, and intraocular lenses. Products are distributed to wholesalers, hospitals, retailers, physicians, nurses, and clinics.
| Indicator | Value |
|---|---|
| PER | 28.8 |
| EV/EBITDA | 13.1 |
| Price/Free Cash Flow' | 22.4 |
| ROIC | 22.4% |
| Net Debt/EBITDA | 0.4 |